Mittie Doyle, CMO at Avalo Therapeutics (NASDAQ:AVTX), sold 679 shares for $13,580 after exercising stock options under a Rule 10b5-1 trading plan. Following these transactions, she directly holds 51,776 shares and 114,413 stock options. This news follows Avalo's inclusion in the Russell 2000 and 3000 indexes, the appointment of Ron Philip to its board, and positive analyst ratings.
Investing.com
Original source
We wrap up our coverage of the markets and the week.
Bitcoin and Ether bears get decimated amid 'squeeze-led' rally and Musk's X wants to pay creators in stablecoins: Crypto's week in 5 stories CoinDesk Why bitcoin prices are suddenly rallying big-time Yahoo Finance Bitcoin jumps further on U.S. crypto policy hopes CP24 Bitcoin and gold surge as Bessent's bond market intervention weighs on dollar Financial Post Gold and Bitcoin Are Rallying as Debasement Chatter Picks Up Bloomberg.com
Last week, the BSE benchmark Sensex declined 276.32 points, or 0.35 per cent, and the NSE Nifty dipped 76.35 points, or 0.31 per cent
Banks, fintechs, NPCI: Who gets what when MDR returns to UPI Moneycontrol.com Keeping UPI accessible, secure and trusted: Balancing free payments with systemic growth Deccan Herald Selective UPI MDR Will Need Reliable Merchant Intelligence, Not Just a Pricing Rule TheWire.in Keep UPI free, and fund it from the savings it generates The Indian Express MDR on UPI transactions worth ₹2,000 & above likely in 2 weeks: Report | Zero MDR was introduced in January 2020 | Inshorts Inshorts
Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer